• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分化人肝癌 HepaRG 细胞中药物转运蛋白的极化表达。

Polarized expression of drug transporters in differentiated human hepatoma HepaRG cells.

机构信息

Institut de Recherches en Santé, Environnement et Travail (IRSET), UMR INSERM U1085, Faculté de Pharmacie, 2 Avenue du Pr Léon Bernard, 35043 Rennes, France.

出版信息

Toxicol In Vitro. 2013 Sep;27(6):1979-86. doi: 10.1016/j.tiv.2013.07.003. Epub 2013 Jul 12.

DOI:10.1016/j.tiv.2013.07.003
PMID:23850984
Abstract

The HepaRG cell line is a well-differentiated human hepatoma cell line proposed as a surrogate for human hepatocytes, especially for hepatic detoxification studies. Polarized status of drug transporters, i.e., their coordinated location at sinusoidal or canalicular membranes, which represents a key hallmark of hepato-biliary drug transport, remains however incompletely documented in HepaRG cells. The present study was therefore designed to analyze transporter location in HepaRG cells, which exhibit mRNA expressions of most of hepatic transporters. HepaRG cells were demonstrated, through immunofluorescence staining, to express several drug transporters at their sinusoidal pole, especially the influx transporters organic anion transporting polypeptide (OATP) 1B1, OATP2B1 and organic cation transporter (OCT) 1 and the efflux transporter multidrug resistance-associated protein (MRP) 3. In addition, the efflux transporters P-glycoprotein and MRP2 were detected at the canalicular pole of HepaRG cells. Moreover, saturable uptake of reference substrates for the sinusoidal transporters sodium-taurocholate cotransporting polypeptide, OATPs and OCT1 and canalicular secretion of reference substrates for the efflux transporters bile salt export pump and MRP2 were observed. This polarized and functional expression of various sinusoidal and canalicular transporters in HepaRG cells highlights the interest of using these hepatoma cells in xenobiotic transport studies.

摘要

HepaRG 细胞系是一种分化良好的人肝癌细胞系,被提议作为人肝细胞的替代物,特别是用于肝解毒研究。然而,药物转运体的极化状态(即它们在窦状或胆管膜处的协调定位)在 HepaRG 细胞中仍然没有得到充分的记录,这是肝胆药物转运的一个关键特征。因此,本研究旨在分析 HepaRG 细胞中转运体的位置,该细胞表达大多数肝转运体的 mRNA。通过免疫荧光染色,HepaRG 细胞被证明在其窦状极表达几种药物转运体,特别是流入转运体有机阴离子转运多肽 (OATP) 1B1、OATP2B1 和有机阳离子转运体 (OCT) 1 以及多药耐药相关蛋白 (MRP) 3。此外,在 HepaRG 细胞的胆管极检测到外排转运体 P-糖蛋白和 MRP2。此外,还观察到参考底物对窦状转运体牛磺胆酸钠共转运多肽、OATPs 和 OCT1 的可饱和摄取以及参考底物对胆汁盐输出泵和 MRP2 的外排转运体的管腔分泌。HepaRG 细胞中各种窦状和胆管转运体的这种极化和功能表达突出了使用这些肝癌细胞进行外源性转运研究的兴趣。

相似文献

1
Polarized expression of drug transporters in differentiated human hepatoma HepaRG cells.分化人肝癌 HepaRG 细胞中药物转运蛋白的极化表达。
Toxicol In Vitro. 2013 Sep;27(6):1979-86. doi: 10.1016/j.tiv.2013.07.003. Epub 2013 Jul 12.
2
Functional expression of sinusoidal and canalicular hepatic drug transporters in the differentiated human hepatoma HepaRG cell line.人源肝癌HepaRG分化细胞系中肝血窦和胆小管肝药物转运体的功能表达
Eur J Pharm Sci. 2006 May;28(1-2):109-17. doi: 10.1016/j.ejps.2006.01.004. Epub 2006 Feb 20.
3
Polarized location of SLC and ABC drug transporters in monolayer-cultured human hepatocytes.溶质载体(SLC)和ATP结合盒(ABC)药物转运体在单层培养的人肝细胞中的极化定位。
Toxicol In Vitro. 2015 Aug;29(5):938-46. doi: 10.1016/j.tiv.2015.03.019. Epub 2015 Apr 7.
4
Down-regulation of organic anion transporter expression in human hepatocytes exposed to the proinflammatory cytokine interleukin 1beta.暴露于促炎细胞因子白细胞介素1β的人肝细胞中有机阴离子转运体表达的下调。
Drug Metab Dispos. 2008 Feb;36(2):217-22. doi: 10.1124/dmd.107.016907. Epub 2007 Nov 8.
5
Regulation of drug transporter expression in human hepatocytes exposed to the proinflammatory cytokines tumor necrosis factor-alpha or interleukin-6.促炎细胞因子肿瘤坏死因子-α或白细胞介素-6作用下人类肝细胞中药物转运体表达的调控
Drug Metab Dispos. 2009 Mar;37(3):685-93. doi: 10.1124/dmd.108.023630. Epub 2008 Dec 15.
6
Differential regulation of drug transporter expression by all-trans retinoic acid in hepatoma HepaRG cells and human hepatocytes.全反式视黄酸对肝癌 HepaRG 细胞和人肝细胞中药物转运体表达的差异调节。
Eur J Pharm Sci. 2013 Mar 12;48(4-5):767-74. doi: 10.1016/j.ejps.2013.01.005. Epub 2013 Jan 23.
7
Differential regulation of drug transporter expression by hepatocyte growth factor in primary human hepatocytes.肝细胞生长因子对原代人肝细胞药物转运体表达的差异调节。
Drug Metab Dispos. 2009 Nov;37(11):2228-35. doi: 10.1124/dmd.109.028035. Epub 2009 Aug 6.
8
Regulation of drug transporter expression by oncostatin M in human hepatocytes.奥曲肽 M 对人肝细胞药物转运体表达的调控。
Biochem Pharmacol. 2011 Aug 1;82(3):304-11. doi: 10.1016/j.bcp.2011.04.017. Epub 2011 May 6.
9
Expression and transport function of drug uptake transporters in differentiated HepaRG cells.分化 HepaRG 细胞中药物摄取转运体的表达和转运功能。
Mol Pharm. 2012 Dec 3;9(12):3434-41. doi: 10.1021/mp300171p. Epub 2012 Nov 6.
10
Comparative Localization and Functional Activity of the Main Hepatobiliary Transporters in HepaRG Cells and Primary Human Hepatocytes.HepaRG细胞和原代人肝细胞中主要肝胆转运蛋白的比较定位与功能活性
Toxicol Sci. 2015 May;145(1):157-68. doi: 10.1093/toxsci/kfv041. Epub 2015 Feb 17.

引用本文的文献

1
Cell-based approaches for the mechanistic understanding of drug-induced cholestatic liver injury.基于细胞的方法用于对药物性胆汁淤积性肝损伤的机制理解
Arch Toxicol. 2025 Mar 11. doi: 10.1007/s00204-025-04016-0.
2
Advances in drug-induced liver injury research: in vitro models, mechanisms, omics and gene modulation techniques.药物性肝损伤研究进展:体外模型、机制、组学及基因调控技术
Cell Biosci. 2024 Nov 2;14(1):134. doi: 10.1186/s13578-024-01317-2.
3
Application of HepaRG cells for genotoxicity assessment: a review.HepaRG 细胞在遗传毒性评估中的应用:综述。
J Environ Sci Health C Toxicol Carcinog. 2024;42(3):214-237. doi: 10.1080/26896583.2024.2331956. Epub 2024 Apr 2.
4
In Vitro Models for Studying Chronic Drug-Induced Liver Injury.用于研究慢性药物性肝损伤的体外模型。
Int J Mol Sci. 2022 Sep 28;23(19):11428. doi: 10.3390/ijms231911428.
5
Inhibition of canalicular and sinusoidal taurocholate efflux by cholestatic drugs in human hepatoma HepaRG cells.在人肝癌 HepaRG 细胞中,胆汁淤积药物抑制胆小管和窦状隙胆盐水流出。
Biopharm Drug Dispos. 2022 Dec;43(6):265-271. doi: 10.1002/bdd.2333. Epub 2022 Oct 27.
6
Expression of Chemoresistance-Associated ABC Proteins in Hepatobiliary, Pancreatic and Gastrointestinal Cancers.化疗耐药相关ABC蛋白在肝胆胰及胃肠道癌症中的表达
Cancers (Basel). 2022 Jul 20;14(14):3524. doi: 10.3390/cancers14143524.
7
Contribution of Humanized Liver Chimeric Mice to the Study of Human Hepatic Drug Transporters: State of the Art and Perspectives.人源化肝嵌合小鼠在研究人类肝药物转运体中的贡献:现状与展望。
Eur J Drug Metab Pharmacokinet. 2022 Sep;47(5):621-637. doi: 10.1007/s13318-022-00782-9. Epub 2022 Jul 6.
8
Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction.特异质性药物性肝损伤(iDILI)的临床前模型:迈向预测
Acta Pharm Sin B. 2021 Dec;11(12):3685-3726. doi: 10.1016/j.apsb.2021.11.013. Epub 2021 Nov 18.
9
Immune-Mediated Drug-Induced Liver Injury: Immunogenetics and Experimental Models.免疫介导的药物性肝损伤:免疫遗传学和实验模型。
Int J Mol Sci. 2021 Apr 27;22(9):4557. doi: 10.3390/ijms22094557.
10
From street to lab: in vitro hepatotoxicity of buphedrone, butylone and 3,4-DMMC.从街头到实验室:丁基酮、丁基硝西泮和 3,4-二甲基甲卡西酮的体外肝毒性。
Arch Toxicol. 2021 Apr;95(4):1443-1462. doi: 10.1007/s00204-021-02990-9. Epub 2021 Feb 7.